Armistice Capital »

Cibus shares owned by Armistice Capital

Quarter-by-quarter ownership of Cibus (CBUS) shares owned by Armistice Capital from 13F filings

Historical chart of Armistice Capital investment in Cibus

Tip: Access up to 7 years of quarterly data

All positions including Cibus held by Armistice Capital consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Cibus by Armistice Capital

Quarter filed Position value Share count Share price at filing
2024-06-30 $5.1M 516k 9.85

More positions owned by Armistice Capital

Spdr S&p 500 Etf Tr Tr Unit Put Option (SPY)
Ishares Tr Russell 2000 Etf Put Option (IWM)
Ptc Therapeutics I (PTCT)
Cytokinetics Com New (CYTK)
Supernus Pharmaceuticals (SUPN)
Neurocrine Biosciences (NBIX)
Incyte Corporation (INCY)
Immunovant (IMVT)
Agios Pharmaceuticals (AGIO)
Argenx Se Sponsored Adr (ARGX)
Novo-nordisk A S Adr (NVO)
Sanofi Sponsored Adr (SNY)
Alkermes SHS (ALKS)
Medtronic SHS (MDT)
Aurinia Pharmaceuticals (AUPH)

View all positions for Armistice Capital

Top funds holding Cibus

Vantage Consulting Group
BlackRock
BlackRock
Vanguard Group
Armistice Capital
Geode Capital Management
State Street Corporation
Northern Trust
CI Private Wealth
Goldman Sachs Group
Charles Schwab Investment Management
Susquehanna International
FineMark National Bank & Trust
Bank of New York Mellon
Swan Wealth Advisors

View all funds holding Cibus